BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16900117)

  • 1. Diagnostics investors think positive.
    Lawrence S
    Nat Biotechnol; 2006 Aug; 24(8):884. PubMed ID: 16900117
    [No Abstract]   [Full Text] [Related]  

  • 2. Upward trend in financing continues, but fewer feel flush.
    Lawrence S
    Nat Biotechnol; 2007 Jan; 25(1):3. PubMed ID: 17211374
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech financing retrenches in Q2.
    Lawrence S
    Nat Biotechnol; 2006 Aug; 24(8):883. PubMed ID: 16900116
    [No Abstract]   [Full Text] [Related]  

  • 4. Beyond the crunch.
    Nat Rev Drug Discov; 2009 Jan; 8(1):3. PubMed ID: 19123266
    [No Abstract]   [Full Text] [Related]  

  • 5. US credit crunch impacts biotech across the globe.
    Mitchell P
    Nat Biotechnol; 2008 Apr; 26(4):359-60. PubMed ID: 18391997
    [No Abstract]   [Full Text] [Related]  

  • 6. Not for the chicken-hearted.
    Nat Biotechnol; 2006 Aug; 24(8):870. PubMed ID: 16900108
    [No Abstract]   [Full Text] [Related]  

  • 7. VC funding hits high in Q1.
    Lawrence S
    Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825
    [No Abstract]   [Full Text] [Related]  

  • 8. The rise of European venture capital for biotechnology.
    Howell M; Trull M; Dibner MD
    Nat Biotechnol; 2003 Nov; 21(11):1287-91. PubMed ID: 14595356
    [No Abstract]   [Full Text] [Related]  

  • 9. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 10. Does biotech M&A benefit investors?
    Jacobs T
    Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
    [No Abstract]   [Full Text] [Related]  

  • 11. 2006: a stellar year for financing.
    Lawrence S
    Nat Biotechnol; 2007 Feb; 25(2):156. PubMed ID: 17287738
    [No Abstract]   [Full Text] [Related]  

  • 12. Where the money is.
    Fitzgerald M
    Nat Biotechnol; 2006 Mar; 24(3):240-2. PubMed ID: 16525370
    [No Abstract]   [Full Text] [Related]  

  • 13. Mixed results in Q1.
    Lawrence S
    Nat Biotechnol; 2005 May; 23(5):518. PubMed ID: 15877059
    [No Abstract]   [Full Text] [Related]  

  • 14. Early-stage returns?
    Booth BL
    Nat Biotechnol; 2006 Nov; 24(11):1335-40. PubMed ID: 17093473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Going strong, going public. Despite spate of chronic problems and calls for reform, healthcare initial public offerings demonstrate fiscal health.
    Zigmond J
    Mod Healthc; 2007 Dec 24-31; 37(51):6-7, 16, 1. PubMed ID: 18220122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic investors: private equity fund expands and diversifies.
    Evans M
    Mod Healthc; 2012 Jun; 42(23):10-1. PubMed ID: 22741425
    [No Abstract]   [Full Text] [Related]  

  • 17. The REIT stuff.
    Pallarito K
    Mod Healthc; 1997 Feb; 27(5):68. PubMed ID: 10164706
    [No Abstract]   [Full Text] [Related]  

  • 18. Bond sales hit the brakes as rates rise.
    Pallarito K
    Mod Healthc; 1994 Apr; 24(16):42. PubMed ID: 10133187
    [No Abstract]   [Full Text] [Related]  

  • 19. Bond volume slows from 1998 record.
    Jaklevic MC
    Mod Healthc; 2000 Jan; 30(4):38. PubMed ID: 11009991
    [No Abstract]   [Full Text] [Related]  

  • 20. Any diamonds in the diagnostic coal?
    Jacobs T
    Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.